The Consortium combines the strengths of our partners to provide access to the most current diagnostic tools and latest cancer treatments including stem cell and bone marrow transplantation, gene therapy, high-dose chemotherapy, radiation therapy, immunotherapy, minimally invasive surgical techniques, and other specialized therapies.